Format

Send to

Choose Destination
Vaccine. 2013 Dec 29;31 Suppl 5:F73-4. doi: 10.1016/j.vaccine.2012.11.077.

Recommendations for cervical cancer prevention in sub-saharan Africa.

Author information

1
Department of Obstetrics and Gynaecology, and Institute of Infectious Diseases and Molecular Medicine, University of Cape Town/Groote Schuur Hospital, Cape Town, South Africa. Electronic address: lynette.denny@uct.ac.za.
2
Early Detection and Prevention Section and Screening Group, International Agency for Research on Cancer (WHO-IARC), Lyon, France.
3
Infection and Cancer Epidemiology Group, International Agency for Research on Cancer (WHO-IARC), Lyon, France.
4
Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA.
5
Department of Obstetrics and Gynaecology, Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria.
6
Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Program (CERP), Institut Català d'Oncologia - Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat (Barcelona), Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.
7
Gynaecological Oncology Unit, Department of Obstetrics and Gynaecology, College of Medicine, University of Ibadan, Nigeria.
8
Department of Obstetrics and Gynecology, UNC Global Women's Health, University of North Carolina - Chapel Hill, North Carolina, USA.
9
Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Program (CERP), Institut Català d'Oncologia - Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat (Barcelona), Spain.
PMID:
24331750
DOI:
10.1016/j.vaccine.2012.11.077
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center